MP:0000603 | pale liver | "liver lacking normal coloration, often refers to bloodless condition" [J:18048] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001828 | abnormal T cell activation | "anomaly in the process of producing effector T cells from naive T cells" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001846 | increased inflammatory response | "greater than expected response to injury, infection, or insult " [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001858 | intestinal inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the intestine" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001859 | kidney inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the kidney" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001860 | liver inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the liver" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001861 | lung inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the lung" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0001870 | salivary gland inflammation | "local accumulation of fluid, plasma proteins, and leukocytes in the salivary gland" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0002499 | chronic inflammation | "persistent inflammatory response, often caused by persistent infection or during an autoimmune response" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0004974 | decreased regulatory T cell number | "reduced number of the specialized subpopulation of T cells that act to suppress activation of the immune system and thus maintain immune system homeostasis and prevent pathological self-reactivity" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0005343 | increased circulating aspartate transaminase level | "greater than normal concentration in the blood of this enzyme, which catalyzes the reversible transfer of an amine group from l-glutamic acid to oxaloacetic acid, forming alpha-ketoglutaric acid and l-aspartic acid; aids in diagnosis of viral hepatitis and myocardial infarction" [Stedman s Medical Dictionary:ISBN 0-683-40008-8, pvb:Pierre Vanden Borre , Mouse Genome Informatics Curator, J:85204] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0005348 | increased T cell proliferation | "increased clonal expansion of naive T cells in response to stimuli" [Immunobiology , The Immune System in Health and Disease:ISBN 0-8153-1691-7, cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0005416 | abnormal circulating protein level | "anomalous blood concentration of any of the macromolecules consisting of long chains of amino acids in peptide linkage" [cwg:Carroll-Ann W. Goldsmith , Mouse Genome Informatics curator, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0005566 | decreased blood urea nitrogen level | "low circulating concentration of nitrogen, in the form of urea; commonly used to measure renal function" [RGD:Rat Genome Database submission, Stedman s Medical Dictionary:ISBN 0-683-40008-8] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008074 | increased CD4-positive T cell number | "greater number of the subset of T lymphocytes that carry the CD4 marker, recognize intravesicular peptides bound to MHC class-II molecules, and turn on antibody production" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008078 | increased CD8-positive T cell number | "greater number of the regulatory subset of T lymphocytes that are involved in MHC class I restricted interactions" [MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008502 | increased IgG3 level | "greater than normal immunoglobulin class G3 level" [MGI:tmeehan "Terry Meehan, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008566 | increased interferon-gamma secretion | "increase in the production or release of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008577 | increased circulating interferon-gamma level | "increase in the amount in the blood of the major interferon produced by mitogenically or antigenically stimulated lymphocytes that is involved in immunoregulation" [MESH:D12.644.276.374.440.893] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008593 | increased circulating interleukin-10 level | "increase in the amount in the blood of a cytokine produced by a variety of cell types, including T-cells, monocytes, dendritic cells and epithelial cells that exerts a variety of effects on immunoregulation and inflammation" [MESH:D12.644.276.374.465.510] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008599 | increased circulating interleukin-2 level | "increase in the amount in the blood of a soluble substance elaborated by antigen- or mitogen-stimulated T-cells which induces DNA synthesis in naive lymphocytes" [MESH:D12.644.276.374.465.502] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008602 | increased circulating interleukin-4 level | "increase in the amount in the blood of a soluble factor produced by activated T-cells that induces the expression of MHC class II genes and FC receptors on B-cells and causes their proliferation and differentiation; it also acts on T-cells, mast cells and several other hematopoietic lineage cells" [MESH:D12.644.276.374.465.504] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008617 | increased circulating interleukin-12 level | "increase in the amount in the blood of a heterodimeric cytokine that plays a role in innate and adaptive immune responses; it is produced by dendritic cells, macrophages and a variety of other immune cells and plays a role in the stimulation of interferon-gamma production by T-cells and natural killer cells" [MESH:D12.644.276.374.465.512] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008647 | increased circulating interleukin-12b level | "increase in the amount in the blood of the p40 cytokine subunit that is a component of both interleukin-12 and interleukin-23" [MESH:D12.644.276.374.465.512.500] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0008681 | increased interleukin-17 secretion | "increase in the production or release of a proinflammatory cytokine produced primarily by T-cells or their precursors" [MESH:D12.644.276.374.465.517] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0010209 | abnormal circulating chemokine level | "deviation from the normal levels of any of the class of pro-inflammatory cytokines that attract and activate leukocytes in the circulation" [MESH:D12.644.276.374.200, MGI:csmith "Cynthia L. Smith, Mouse Genome Informatics Curator"] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|
MP:0013763 | increased T-helper cell number | "increase in the number of an effector T cell that provides help in the form of secreted cytokines to other immune cells" [CL:0000912] |
Show
Allelic Composition: Slc6a19bucp-2J/Slc6a19bucp-2J Genetic Background: FVB/NJ-Slc6a19bucp-2J/GrsrJ
|